Ghana gives clearance to Oxford malaria vaccine

Apr 14, 2023, at 06:24 pm

The University of Oxford-developed and Serum Institute of India PvT Ltd (SIIPL)- manufactured and scaled up R21/Matrix-MTM malaria vaccine, leveraging Novavax’s adjuvant technology, has been licensed for use in Ghana by the country’s Food and Drugs Authority

COVID-19: Oxford vaccine shows 70 percent efficiency 

Nov 23, 2020, at 08:31 pm

London: Oxford University’s AstraZeneca vaccine candidate, AZD1222, which is being developed against COVID-19 disease has shown 70 percent efficiency on average, officials said.

Oxford Vaccine trials resume in UK days after pause over volunteer's illness

Sep 13, 2020, at 02:48 am

London/IBNS: Pharmaceutical giant AstraZeneca on Saturday resumed the trials of Covid-19 vaccine in the United Kingdom after a brief halt following a volunteer's illness, media reports said.

India adds close to 61,000 Covid-19 cases, 848 deaths in 24 hours

Aug 25, 2020, at 05:16 pm

New Delhi/IBNS: India, which has been badly-hit by the Novel Coronavirus pandemic, added close to 61,000 fresh infections on Tuesday.

Oxford University's COVID-19 vaccine triggers 'strong immune response'

Jul 21, 2020, at 01:50 am

London/IBNS: Setting a big mark of progress, a coronavirus vaccine developed by the University of Oxford has produced a strong immune response and appeared to be safe, a new study revealed on Monday.

Heart failure survival rates show no improvement, says study

Jan 31, 2017, at 11:12 pm

London, Jan 31 (IBNS): Survival rates for people suffering from heart failure have not improved since 1998, according to a study led by University of Oxford researchers.